Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 October 2019 | Story Nikile Ntsababa (Registrar)

The nomination process for the election of two representatives to serve on the UFS Council was finalised on Tuesday, 17 September 2019 – the closing date for nominations.
 
Here are the names of the nominees (listed alphabetically):
 
Representative from the Qwaqwa Campus:
None
 
Other representative:
Mr Christo Dippenaar
Dr Pieter du Toit
Mr Lefa Mabaso
Dr Walter Matli
Mr Zama Sigwebela
 
Please note that no nominations were received for representatives from the Qwaqwa Campus.  Since this scenario is not legislated in the Statute, Institutional Rules, and Convocation Constitution, the Registrar will, after consultation with the President of the Convocation, open another round of nominations for Qwaqwa representatives to Council (with the closing date 8 October 2019) to ensure that the campus is also represented on Council.
 
Convocation and Alumni members from the Qwaqwa Campus are therefore given a second opportunity to nominate one representative from among their members for the Qwaqwa Campus.  All nominations must reach the office of the Registrar no later than 16:30 on Wednesday, 9 October 2019.
 
Every nomination form  shall be signed by four (4) members of the Convocation and shall contain the written acceptance of the nomination by the nominee under his/her signature as well as an abridged CV and a motivation of more or less 200 words.
 
Nominations are to be submitted to:  email: registrar@ufs.ac.za or delivered by hand to Nikile Ntsababa, Main Building, Room 51, Bloemfontein Campus.
 
Kindly take note that late or incomplete nominations will not be accepted or considered.
 
Further information regarding the election process will follow in due course.

News Archive

New Division of Virology to deliver crucial services for HIV diagnosis and resistance testing
2015-12-14

The establishment of a Division of Virology within the Department of Medical Microbiology, under the joint auspices of the UFS and the National Health Laboratory Service (NHLS), reflects the continued growth within Virology.  Dr Dominique Goedhals, Head of the Division, says the division will also provide training of undergraduate medical students, medical technologists and technicians, and registrars.

The newly established Division of Virology at the University of the Free State will be one of only five laboratories in the country to be involved in crucial diagnostic and testing services for HIV viral load monitoring, early infant diagnosis, and HIV resistance testing.

The Virology Diagnostic Laboratory serves as the reference laboratory for all HIV National Priority Programme samples for the Free State and Northern Cape provinces.

Medical staff at the laboratory will provide a 24-hour consultative service, as well as outreach programmes to district laboratories in the Free State and Northern Cape where pathologists are not available. 

Dr Dominique Goedhals, Head of the Division of Virology, says this division, under the joint auspices of the UFS and the National Health Laboratory Service (NHLS), reflects the continued growth within Virology.

The division will not only deliver this critical diagnostic service, but will also focus on training and teaching, as well as research.

Teaching and training activities include teaching of undergraduate medical students, medical technologists and technicians, and registrars.  The postgraduate science programme has a high output of honours, master’s and doctoral students in Virology.  The intern medical scientist programme is also active, with five interns having successfully submitted their portfolios since the programme was implemented in 2010.

Research activities under the Head of Research, Prof Felicity Burt, have also expanded and continue to show increases in publication output and acquisition of grant funding.  Established research groups within the Division of Virology focus on vector-borne and zoonotic viruses, human papilloma viruses (HPV), and human immunodeficiency virus (HIV), as well as work with a number of international collaborators.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept